Подписаться
Tetyana Falalyeyeva, Тетяна Фалалєєва
Tetyana Falalyeyeva, Тетяна Фалалєєва
Professor, Taras Shevchenko National University of Kyiv
Подтвержден адрес электронной почты в домене knu.ua
Название
Процитировано
Процитировано
Год
Pathophysiological role of host microbiota in the development of obesity
N Kobyliak, O Virchenko, T Falalyeyeva
Nutrition journal 15, 1-12, 2015
1782015
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018
1742018
Treatment efficacy of a probiotic preparation for non‐alcoholic steatohepatitis: a pilot trial
E Manzhalii, O Virchenko, T Falalyeyeva, T Beregova, W Stremmel
Journal of digestive diseases 18 (12), 698-703, 2017
972017
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ...
852018
Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease
L Abenavoli, T Falalyeyeva, L Boccuto, O Tsyryuk, N Kobyliak
Pharmaceuticals 11 (4), 104, 2018
792018
The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention
OA Savcheniuk, OV Virchenko, TM Falalyeyeva, TV Beregova, ...
EPMA Journal 5, 1-17, 2014
772014
Crosstalk between gut microbiota and antidiabetic drug action
Y Kyriachenko, T Falalyeyeva, O Korotkyi, N Molochek, N Kobyliak
World journal of diabetes 10 (3), 154, 2019
722019
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult …
O Savcheniuk, N Kobyliak, M Kondro, O Virchenko, T Falalyeyeva, ...
BMC complementary and alternative medicine 14, 1-17, 2014
692014
Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative …
NM Kobyliak, TM Falalyeyeva, OG Kuryk, TV Beregova, PM Bodnar, ...
EPMA Journal 6, 1-22, 2015
682015
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
N Kobyliak, O Virchenko, T Falalyeyeva, M Kondro, T Beregova, P Bodnar, ...
Biomedicine & Pharmacotherapy 90, 608-614, 2017
672017
Probiotics and nutraceuticals as a new frontier in obesity prevention and management
N Kobyliak, T Falalyeyeva, N Boyko, O Tsyryuk, T Beregova, ...
Diabetes research and clinical practice 141, 190-199, 2018
592018
Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity
N Kobyliak, T Falalyeyeva, P Bodnar, T Beregova
Probiotics and Antimicrobial Proteins 9, 123-130, 2017
442017
Efficacy of probiotics and smectite in rats with non-alcoholic fatty liver disease
N Kobyliak, L Abenavoli, T Falalyeyeva, T Beregova
Annals of hepatology 17 (1), 153-161, 2018
412018
Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles
N Kobyliak, L Abenavoli, T Falalyeyeva, O Virchenko, B Natalia, ...
Clujul Medical 89 (2), 229, 2016
402016
Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A …
N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, N Molochek, O Savchuk, ...
Obesity Medicine 19, 100248, 2020
372020
Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition
N Kobyliak, T Falalyeyeva, T Beregova, M Spivak
Endokrynologia Polska 68 (6), 659-667, 2017
362017
Comparative experimental investigation on the efficacy of mono-and multiprobiotic strains in non-alcoholic fatty liver disease prevention
N Kobyliak, T Falalyeyeva, O Virchenko, G Mykhalchyshyn, P Bodnar, ...
BMC gastroenterology 16, 1-9, 2016
362016
New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study
N Kobyliak, T Falalyeyeva, O Tsyryuk, M Eslami, D Kyriienko, T Beregova, ...
Journal of Diabetes & Metabolic Disorders 19, 289-296, 2020
322020
Probiotics and obesity associated disease: an extended view beyond traditional strains.
T Falalyeyeva, Y Mamula, E Scarpellini, I Leshchenko, A Humeniuk, ...
Minerva Gastroenterology 67 (4), 348-356, 2021
302021
Probiotic composition and chondroitin sulfate regulate TLR-2/4-mediated NF-κB inflammatory pathway and cartilage metabolism in experimental osteoarthritis
O Korotkyi, A Huet, K Dvorshchenko, N Kobyliak, T Falalyeyeva, ...
Probiotics and Antimicrobial Proteins, 1-15, 2021
292021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20